For: | Xiang H, Liu QP. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential. World J Gastroenterol 2022; 28(47): 6689-6701 [PMID: PMC9813939 DOI: 10.3748/wjg.v28.i47.6689] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i47/6689.htm |
Number | Citing Articles |
1 |
Sterlin T. Raj, Alexander W. Bruce, Muralidharan Anbalagan, Hemalatha Srinivasan, Sasikala Chinnappan, Mogana Rajagopal, Kushagra Khanna, Harish C. Chandramoorthy, Ravishankar Ram Mani. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1384939
|
2 |
Angela Saviano, Mattia Brigida, Carmine Petruzziello, Christian Zanza, Marcello Candelli, Maria Rita Morabito Loprete, Faiz Saleem, Veronica Ojetti. Intestinal Damage, Inflammation and Microbiota Alteration during COVID-19 Infection. Biomedicines 2023; 11(4): 1014 doi: 10.3390/biomedicines11041014
|
3 |
Rabia Maqsood, LaRinda A. Holland, Lily I. Wu, Emily R. Begnel, Judith Adhiambo, Prestone Owiti, Bhavna H. Chohan, Soren Gantt, John Kinuthia, Dalton Wamalwa, Ednah Ojee, Barbra A. Richardson, Jennifer Slyker, Dara A. Lehman, Efrem S. Lim. Gut virome and microbiome dynamics before and after SARS-CoV-2 infection in women living with HIV and their infants. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2394248
|
4 |
Jacob D. Wilson, Michaela Dworsky-Fried, Nafissa Ismail. Neurodevelopmental implications of COVID-19-induced gut microbiome dysbiosis in pregnant women. Journal of Reproductive Immunology 2024; 165: 104300 doi: 10.1016/j.jri.2024.104300
|
5 |
Luiza Tomé Mendes, Marcos C. Gama-Almeida, Desirée Lopes Reis, Ana Carolina Pires e Silva, Rômulo Leão Silva Neris, Rafael Mello Galliez, Terezinha Marta Pereira Pinto Castiñeiras, Christian Ludwig, Ana Paula Valente, Gilson Costa dos Santos Junior, Tatiana El-Bacha, Iranaia Assunção-Miranda. Longitudinal 1H NMR-Based Metabolomics in Saliva Unveils Signatures of Transition from Acute to Post-Acute Phase of SARS-CoV-2 Infection. Viruses 2024; 16(11): 1769 doi: 10.3390/v16111769
|
6 |
Zengbin Li, Guixian Zhu, Xiangye Lei, Liqiong Tang, Guangyao Kong, Mingwang Shen, Lei Zhang, Lingqin Song. Genetic support of the causal association between gut microbiome and COVID-19: a bidirectional Mendelian randomization study. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1217615
|
7 |
Sepp Fegerl. Prävention und Therapie viraler Epidemien. 2024; : 139 doi: 10.1007/978-3-662-67508-3_8
|
8 |
Leonardo Mancabelli, Giuseppe Taurino, Andrea Ticinesi, Tecla Ciociola, Federica Vacondio, Christian Milani, Federico Fontana, Gabriele Andrea Lugli, Chiara Tarracchini, Giulia Alessandri, Alice Viappiani, Massimiliano Bianchi, Antonio Nouvenne, Alfredo Antonio Chetta, Francesca Turroni, Tiziana Meschi, Marco Mor, Ovidio Bussolati, Marco Ventura, Paolo Visca. Disentangling the interactions between nasopharyngeal and gut microbiome and their involvement in the modulation of COVID-19 infection. Microbiology Spectrum 2023; 11(5) doi: 10.1128/spectrum.02194-23
|
9 |
Yong Qiu, Chunheng Mo, Lu Chen, Wanlin Ye, Guo Chen, Tao Zhu. Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions. MedComm 2024; 5(4) doi: 10.1002/mco2.513
|
10 |
Pavlo Petakh, Iryna Kamyshna, Aleksandr Kamyshnyi. Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1260633
|
11 |
Jheng-Yan Wu, Po-Yu Huang, Ting-Hui Liu, Chia-Yin Kuo, Ya-Wen Tsai, Hung-Jen Tang, Chih-Cheng Lai. Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. Expert Review of Anti-infective Therapy 2023; 21(6): 667 doi: 10.1080/14787210.2023.2189100
|
12 |
Bijita Bhowmick, Anirban Roy, Avipsha Sarkar, Tanusree Ghorai, Debadatta Nayak, Satadal Das. Implication of iron overload in COVID-19 pathogenesis and long COVID: a mechanistic review. Future Virology 2024; 19(14-15): 525 doi: 10.1080/17460794.2024.2440254
|
13 |
Teodor Cerbulescu, Flavia Ignuta, Uma Shailendri Rayudu, Maliha Afra, Ovidiu Rosca, Adrian Vlad, Stana Loredana. Inflammatory Markers and Severity in COVID-19 Patients with Clostridioides Difficile Co-Infection: A Retrospective Analysis Including Subgroups with Diabetes, Cancer, and Elderly. Biomedicines 2025; 13(1): 227 doi: 10.3390/biomedicines13010227
|
14 |
Bohao Li, Junlu Bai, Yan Xiong, Dong Guo, Beibei Fu, Guohong Deng, Haibo Wu. Understanding the mechanisms and treatments of long COVID to address future public health risks. Life Sciences 2024; 353: 122938 doi: 10.1016/j.lfs.2024.122938
|